China on Thursday said 22 COVID-19 vaccine candidates have entered clinical trials in the country.
“China has approved 22 COVID-19 vaccine candidates for clinical trials,” said Yuan Lin, an official with the National Medical Products Administration, according to public broadcaster CGTN.
Four of the vaccine candidates have been given conditional marketing approval while three others are authorized for emergency use, Yuan added.
China has administered over 1.3 billion vaccine doses in the country and exported its vaccines to over 70 countries and international organizations.
According to the National Health Commission, China registered 17 new cases of COVID-19 on Thursday, including 15 imported.
The country has so far reported a total of 91,966 coronavirus cases, including 4,636 deaths.Anadolu Agency website contains only a portion of the news stories offered to subscribers in the AA News Broadcasting System (HAS), and in summarized form. Please contact us for subscription options.